Karyopharm Therapeutics Welcomes Lori Macomber as CFO to Drive Growth in Cancer Therapies Karyopharm Therapeutics has appointed Lori Macomber as Chief Financial Officer to enhance their financial strategy and expand treatment options for cancer patients.

Karyopharm Therapeutics Welcomes Lori Macomber as CFO to Drive Growth in Cancer Therapies #United_States #Karyopharm #XPOVIO #Newton #Lori_Macomber